A Study of TRS01 in Participants With Post-surgical Ocular Inflammation
Clinical trial NCT04222725 · COMPLETED
Trial details
- NCT number
- NCT04222725
- Sponsor
- Tarsier Pharma
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-01
- Primary completion
- 2020-07-17
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.